Cargando…

A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genes

Hepatocellular carcinoma (HCC) is the most prevalent form of primary liver cancer, accounting for over 90% of cases. As pyruvate metabolic pathways are often dysregulated in cancer cells, investigating pyruvate metabolism-related genes may help identify prognostic gene signature and develop potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Qingmiao, Xue, Chen, Zeng, Yifan, Gu, Xinyu, Wang, Jinzhi, Li, Lanjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275940/ https://www.ncbi.nlm.nih.gov/pubmed/37328616 http://dx.doi.org/10.1038/s41598-023-37000-8

Ejemplares similares

Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes
por: Shi, Qingmiao, et al.
Publicado: (2023)

Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma
por: Shi, Qingmiao, et al.
Publicado: (2020)

Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
por: Shi, Qingmiao, et al.
Publicado: (2023)

Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes
por: Xue, Chen, et al.
Publicado: (2022)

ALYREF mediates RNA m(5)C modification to promote hepatocellular carcinoma progression
por: Xue, Chen, et al.
Publicado: (2023)

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

Integrated bioinformatics analysis reveals the function and prognostic value of OSBPL3 in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

Simultaneous Inhibition of Ornithine Decarboxylase 1 and Pyruvate Kinase M2 Exerts Synergistic Effects Against Hepatocellular Carcinoma Cells
por: Zeng, Zhirui, et al.
Publicado: (2020)

Mitochondrial pyruvate carrier 1: a novel prognostic biomarker that predicts favourable patient survival in cancer
por: Xue, Chen, et al.
Publicado: (2021)

Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma
por: Yuan, Chaoyan, et al.
Publicado: (2021)

A novel fatty acid metabolism-related gene prognostic signature and candidate drugs for patients with hepatocellular carcinoma
por: Yang, Jingze, et al.
Publicado: (2023)

A novel prognostic signature for hepatocellular carcinoma based on SUMOylation-related genes
por: Wang, Jianping, et al.
Publicado: (2023)

The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment
por: Xue, Chen, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
por: Li, Yaoting, et al.
Publicado: (2023)

Function of mitochondrial pyruvate carriers in hepatocellular carcinoma patients
por: Ma, Xiangming, et al.
Publicado: (2018)

Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
por: Ding, Linchao, et al.
Publicado: (2022)

A novel ferroptosis phenotype‐related clinical‐molecular prognostic signature for hepatocellular carcinoma
por: Deng, Tuo, et al.
Publicado: (2021)

Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma
por: Cui, Lijuan, et al.
Publicado: (2020)

Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma
por: Tang, Chaozhi, et al.
Publicado: (2020)

Prognostic value of fatty acid metabolism-related genes in patients with hepatocellular carcinoma
por: He, Dongsheng, et al.
Publicado: (2021)

miR-122 Targets Pyruvate Kinase M2 and Affects Metabolism of Hepatocellular Carcinoma
por: Liu, Angela M., et al.
Publicado: (2014)

Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
por: Xue, Chen, et al.
Publicado: (2023)

Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2022)

A novel hypoxia-driven gene signature that can predict the prognosis of hepatocellular carcinoma
por: Zeng, Zhirui, et al.
Publicado: (2022)

Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients
por: Liu, Jun, et al.
Publicado: (2022)

A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Zhihao, et al.
Publicado: (2021)

A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

The Prognostic Significance and Potential Mechanism of Ferroptosis-Related Genes in Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma
por: Qin, Peng, et al.
Publicado: (2021)

A novel metabolism-related gene signature in patients with hepatocellular carcinoma
por: Ru, Bin, et al.
Publicado: (2023)

Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2021)

Integrative analysis of the characteristic of lipid metabolism-related genes for the prognostic prediction of hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2022)

Development and validation of robust metabolism‐related gene signature in the prognostic prediction of hepatocellular carcinoma
por: Pan, Yangxun, et al.
Publicado: (2023)

Development and validation of a copper-related gene prognostic signature in hepatocellular carcinoma
por: Shi, Haoting, et al.
Publicado: (2023)

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021)

The Multifaceted Pyruvate Metabolism: Role of the Mitochondrial Pyruvate Carrier
por: Zangari, Joséphine, et al.
Publicado: (2020)

ME2 Promotes Hepatocellular Carcinoma Cell Migration through Pyruvate
por: Yang, Yanting, et al.
Publicado: (2023)

A novel focal adhesion related gene signature for prognostic prediction in hepatocellular carcinoma
por: Lin, Zhuo, et al.
Publicado: (2021)

A novel prognostic prediction model of cuprotosis-related genes signature in hepatocellular carcinoma
por: Shao, Ruo-Nan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ovegfqsqqdrolf0jbe633q4o81